Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
3.300
+0.070 (2.17%)
At close: Jan 2, 2026, 4:00 PM EST
3.280
-0.020 (-0.61%)
After-hours: Jan 2, 2026, 4:00 PM EST
Alaunos Therapeutics Employees
Alaunos Therapeutics had 1 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$6,000
Profits / Employee
-$4,025,000
Market Cap
7.37M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1 | 0 | - |
| Dec 31, 2023 | 1 | -33 | -97.06% |
| Dec 31, 2022 | 34 | -7 | -17.07% |
| Dec 31, 2021 | 41 | -65 | -61.32% |
| Dec 31, 2020 | 106 | 33 | 45.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TCRT News
- 6 months ago - Alaunos Therapeutics Announces $2.0 Million Registered Direct Offering - GlobeNewsWire
- 8 months ago - PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), To File Schedule 13D Reporting 5.09% Stake in Alaunos Therapeutics, Inc. (Nasdaq: TCRT) - GlobeNewsWire
- 2 years ago - Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives - GlobeNewsWire
- 2 years ago - Top 5 Health Care Stocks That Could Blast Off This Month - Allakos (NASDAQ:ALLK), BioLife Solns (NASDAQ:BLFS) - Benzinga
- 2 years ago - Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives - GlobeNewsWire
- 2 years ago - Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic Malignancies - GlobeNewsWire
- 2 years ago - Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual Meeting - GlobeNewsWire
- 2 years ago - Alaunos Therapeutics, Inc. (TCRT) Q1 2023 Earnings Call Transcript - Seeking Alpha